A Series of Events on MedTechRobots in the operating room, AI spotting invisible patterns, and home sensors and wearables detecting illness before symptoms appear: technology is changing how we approach prevention, treatment, and living better, longer — while the heart of care stays human.Surgical robotics and clinical AIElderly care and assistive technologiesWearables and home sensors Ethics, dignity, and the human contractThe innovation ecosystem: startups, research, and MedTech solutionsThe hospital of 2035Science and technology transfer   Human+ Healthcare Dialogue no.1: April 18, 2026Presenting our strategic vision were:Riccardo Donadon, Founder and CEO of H-FARMDiego Pizzocaro, CEO of H-FARM AIMauro Fantin, Chief Technology Officer of H-ealthAlso on display were the healthcare projects developed during the Robots in Action hackathon with Jakidale, held on campus on April 11–12.

Human+ Healthcare Dialogue no.2: May 26, 2026This event was in partnership with ULSS 2 Marca Trevigiana, the local public healthcare authority serving the Treviso area, and was focused on bringing innovation, technology, and research into the healthcare system. Participants included the Director General of ULSS 2, Giancarlo Bizzarri, together with the entire Board of Directors, the Regional Councilor for Health, Gino Gerosa, the Regional Councilor for Social Services, Paola Roma, the Director General of the Regional Health and Social Care Area, Giancarlo Ruscitti, the strategic leadership team of ULSS 3, and Lorenzo Megliola, founder of KaiMed.

Human+ Healthcare Dialogue no.3 – Life Redesigned: September 29, 2026RegistERFor centuries we studied biology. Now we build with it: drugs, tissues, cells. These speakers will show us how:Capital, regulations, and the National Biotechnology PlanMarica NobileDirector of Assobiotec-Federchimica, the Italian biotech association.The mindset needed to accelerate or fund a biotech startupDavide EderleHead of Innovation at Città della Speranza and Vice President of ALISEI, Italy's life sciences cluster.How global capital evaluates biotechMaddalena AdornoOperating Partner at BioInnovation Institute and co-founder of Dorian Therapeutics, acquired by Altos Labs.When research turns into a productAnna TampieriResearcher and founder of GreenBone Ortho, bone grafts derived from rattan wood.For science to work, it has to be manufacturableMassimiliano CesariniCEO of Biogenera, DNA-based therapies for pediatric cancers, in clinical trials from 2026.Two opposite business models out of the same labEmiliano BiasiniRuns a Dulbecco Telethon lab on rare genetic diseases. Co-founded Sibylla Biotech, €23M raised, and BrightMol.How a large pharma company turns market signals into decisionsGiorgia IegianiCompetitive Intelligence Specialist at Chiesi Farmaceutici.This event is part of European Biotech Week, coordinated and promoted nationally by Assobiotec-Federchimica.